133 related articles for article (PubMed ID: 7479929)
21. Molecular therapy for peritoneal dissemination of xenotransplanted human MKN-45 gastric cancer cells with adenovirus mediated Bax gene transfer.
Tsunemitsu Y; Kagawa S; Tokunaga N; Otani S; Umeoka T; Roth JA; Fang B; Tanaka N; Fujiwara T
Gut; 2004 Apr; 53(4):554-60. PubMed ID: 15016751
[TBL] [Abstract][Full Text] [Related]
22. Bcl-2, Bcl-XL and adenovirus protein E1B19kD are functionally equivalent in their ability to inhibit cell death.
Huang DC; Cory S; Strasser A
Oncogene; 1997 Jan; 14(4):405-14. PubMed ID: 9053837
[TBL] [Abstract][Full Text] [Related]
23. Apoptosis induction in prostate cancer cells and xenografts by combined treatment with Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand and CPT-11.
Ray S; Almasan A
Cancer Res; 2003 Aug; 63(15):4713-23. PubMed ID: 12907654
[TBL] [Abstract][Full Text] [Related]
24. Engraftment of SCID mice by human bone marrow hematopoietic cells cultured in vitro: an in vivo model for human gene transfer.
Spence SE; Keller JR; Ruscetti FW; Czarra KT; Gooya JM; Funakoshi S; Longo DL; Murphy WJ
Leukemia; 1995 Oct; 9 Suppl 1():S43-7. PubMed ID: 7475312
[TBL] [Abstract][Full Text] [Related]
25. In bone marrow derived Baf-3 cells, inhibition of apoptosis by IL-3 is mediated by two independent pathways.
Leverrier Y; Thomas J; Perkins GR; Mangeney M; Collins MK; Marvel J
Oncogene; 1997 Jan; 14(4):425-30. PubMed ID: 9053839
[TBL] [Abstract][Full Text] [Related]
26. A novel single tetracycline-regulative adenoviral vector for tumor-specific Bax gene expression and cell killing in vitro and in vivo.
Gu J; Zhang L; Huang X; Lin T; Yin M; Xu K; Ji L; Roth JA; Fang B
Oncogene; 2002 Jul; 21(31):4757-64. PubMed ID: 12101414
[TBL] [Abstract][Full Text] [Related]
27. Caspase activation and changes in Bcl-2 family member protein expression associated with E2F-1-mediated apoptosis in human esophageal cancer cells.
Yang HL; Dong YB; Elliott MJ; Liu TJ; McMasters KM
Clin Cancer Res; 2000 Apr; 6(4):1579-89. PubMed ID: 10778992
[TBL] [Abstract][Full Text] [Related]
28. [Therapeutic effects of adenovirus-bcl-xs gene to the ascites tumor of nude mice model of human ovarian carcinoma].
Chen A; Peng Z; Wang H
Zhonghua Fu Chan Ke Za Zhi; 2001 Mar; 36(3):165-7. PubMed ID: 11783395
[TBL] [Abstract][Full Text] [Related]
29. E2F-1 gene therapy induces apoptosis and increases chemosensitivity in human pancreatic carcinoma cells.
Elliott MJ; Farmer MR; Atienza C; Stilwell A; Dong YB; Yang HL; Wong SL; McMasters KM
Tumour Biol; 2002; 23(2):76-86. PubMed ID: 12065845
[TBL] [Abstract][Full Text] [Related]
30. HA14-1 selectively induces apoptosis in Bcl-2-overexpressing leukemia/lymphoma cells, and enhances cytarabine-induced cell death.
Lickliter JD; Wood NJ; Johnson L; McHugh G; Tan J; Wood F; Cox J; Wickham NW
Leukemia; 2003 Nov; 17(11):2074-80. PubMed ID: 12931228
[TBL] [Abstract][Full Text] [Related]
31. Oncogenic Vav1 induces Rac-dependent apoptosis via inhibition of Bcl-2 family proteins and collaborates with p53 deficiency to promote hematopoietic progenitor cell proliferation.
Gu Y; Siefring JE; Wang L; Chae HD; Bailey JR; Zheng Y
Oncogene; 2006 Jun; 25(28):3963-72. PubMed ID: 16474842
[TBL] [Abstract][Full Text] [Related]
32. Smac induces cytochrome c release and apoptosis independently from Bax/Bcl-x(L) in a strictly caspase-3-dependent manner in human carcinoma cells.
Hasenjäger A; Gillissen B; Müller A; Normand G; Hemmati PG; Schuler M; Dörken B; Daniel PT
Oncogene; 2004 Jun; 23(26):4523-35. PubMed ID: 15064710
[TBL] [Abstract][Full Text] [Related]
33. hTERT promoter induces tumor-specific Bax gene expression and cell killing in syngenic mouse tumor model and prevents systemic toxicity.
Gu J; Andreeff M; Roth JA; Fang B
Gene Ther; 2002 Jan; 9(1):30-7. PubMed ID: 11850720
[TBL] [Abstract][Full Text] [Related]
34. Cytokine-mobilized peripheral blood CD34+Thy-1+Lin- human hematopoietic stem cells as target cells for transplantation-based gene therapy.
Chen BP; Fraser C; Reading C; Murray L; Uchida N; Galy A; Sasaki D; Tricot G; Jagannath S; Barlogie B
Leukemia; 1995 Oct; 9 Suppl 1():S17-25. PubMed ID: 7475307
[TBL] [Abstract][Full Text] [Related]
35. Breast cancer cells release factors that induced apoptosis in human bone marrow stromal cells.
Fromigué O; Kheddoumi N; Lomri A; Marie PJ; Body JJ
J Bone Miner Res; 2001 Sep; 16(9):1600-10. PubMed ID: 11547830
[TBL] [Abstract][Full Text] [Related]
36. Vascular endothelial growth factor inhibits apoptotic death in hematopoietic cells after exposure to chemotherapeutic drugs by inducing MCL1 acting as an antiapoptotic factor.
Katoh O; Takahashi T; Oguri T; Kuramoto K; Mihara K; Kobayashi M; Hirata S; Watanabe H
Cancer Res; 1998 Dec; 58(23):5565-9. PubMed ID: 9850095
[TBL] [Abstract][Full Text] [Related]
37. Apoptosis signaling pathways in normal T cells: differential activity of Bcl-2 and IL-1beta-converting enzyme family protease inhibitors on glucocorticoid- and Fas-mediated cytotoxicity.
Moreno MB; Memon SA; Zacharchuk CM
J Immunol; 1996 Nov; 157(9):3845-9. PubMed ID: 8892614
[TBL] [Abstract][Full Text] [Related]
38. Targeting cancer cell death with a bcl-XS adenovirus.
Han JS; Núñez G; Wicha MS; Clarke MF
Springer Semin Immunopathol; 1998; 19(3):279-88. PubMed ID: 9580270
[TBL] [Abstract][Full Text] [Related]
39. Bcl-xL promotes metastasis of breast cancer cells by induction of cytokines resistance.
Fernández Y; España L; Mañas S; Fabra A; Sierra A
Cell Death Differ; 2000 Apr; 7(4):350-9. PubMed ID: 10773819
[TBL] [Abstract][Full Text] [Related]
40. IL-4 and insulin-like growth factor-I inhibit the decline in Bcl-2 and promote the survival of IL-3-deprived myeloid progenitors.
Minshall C; Arkins S; Straza J; Conners J; Dantzer R; Freund GG; Kelley KW
J Immunol; 1997 Aug; 159(3):1225-32. PubMed ID: 9233617
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]